Medical Biomimetics Market Size, Growth, Trends, Report 2027

Summary

Report Description

The global medical biomimetics market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing occurrences of chronic diseases, increasing applications of medical biomimetics, and extensive development in technology are curbing the growth of the market. Biomimetics is an interdisciplinary field which comprises from biology, engineering, and chemistry. It is used for development of biocompatible material which allows healthcare experts to monitor and treat chronic diseases. It is used for regenerative medicine, tissue engineering, and drug delivery. The other factors supporting the market’s growth are, rise in R&D activities, increasing favorable government funding, growing incidences of organ failure, the rising healthcare expenditure in developed and developing economies, rise in aging population base, growing number of mergers and strategic acquisitions, growing life expectancy, and rise in demand for prosthesis and implants.

Increasing Prevalence of Chronic Diseases

The growing occurrences of chronic diseases such as cardiovascular diseases, diabetes, and others, are bolstering the growth of the market, globally. Owing to the sedentary lifestyle and unhealthy eating choices, people are suffering from these diseases, which propels the growth of the market. For instance, as per the Centers for Disease Control and Prevention (CDC) roughly every 40 seconds an American die from a heart attack. It is estimated that 805,000 Americans have a heart attack every year, 605,000 of them for the first time. Geriatric populations are highly prone to diseases such as orthopedic diseases, cardiovascular diseases as well as neurological disorders. Thus, increasing the growth of the medical biomimetics market. According to the National Kidney Foundation, one in four women and one in five men aged between 65 to 74 years have chronic kidney disease across the globe.

Advancements in Biomimetic Technologies

Rapid advancements such as robotics, 3D printing technology, and others in the healthcare sector are surging the growth of the market. The increasing adoption of various innovations in areas of nanotechnology, tissue engineering, and others is expected to create numerous opportunities, which curb the market growths. Adoption of nanotechnology can aid in development of personalized medicine, organ regeneration, plastic surgery, and drug delivery. For instance, in the U.S, in 2020, Veryan Medical launched novel BioMimics 3D vascular stent system. BioMimics is a system which aims for superb outcomes in clinical trials.

Increasing Applications of Biomimetics

Growing demand of biomimetics in medical sector is fueling the growth of the market. This is attributed to the increasing application in various field such as dentistry, cardiology, orthopedics, ophthalmology, and others. Biomimetics are used for treatment of various diseases such as Alzheimer, for prosthetics, organ transplant and others. Moreover, upsurge in the application of medical biomimetics in noninvasive procedures including ECGs, CT scans, and ultrasound in healthcare industry are anticipated to curb the growth in the market. For instance, as per the U.S. government's data, in 2017, approximately 34,770 transplants were conducted in the nation.

Download Free Sample Report

Market Segmentation

The global medical biomimetics market is segmented into type, application, and company. Based on type, the market is divided into cardiovascular, orthopedic, ophthalmology, dental, and others. Based on application, the market is divided into wound healing, tissue engineering, drug delivery, plastic surgery, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rise in the adoption rate of novel technology in the country.

Market Players

Wright Medical Group N.V., Abbott Laboratories, Inc., Blatchford Group (Chas. A. Blatchford & Sons Ltd), BioHorizons IPH, Inc., Biomimetics Technology Inc, SynTouch Inc., Vandstrom, Inc., Gelesis, Inc., BioTomo Pty. Ltd., and Hstar Technologies Corporation are some of the leading companies operating in the market.

Attribute	Details
Base Year	2021
Historic Data	2017 – 2020
Estimated Year	2022
Forecast Period	2023 – 2027
Quantitative Units	Revenue in USD Million, Volume Units and CAGR for 2017-2021 and 2022-2027
Report coverage	Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends
Segments covered	· Type · Application · Company
Regional scope	North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa
Country scope	United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa; Turkey; Egypt;
Key companies profiled	Wright Medical Group N.V., Abbott Laboratories, Inc., Blatchford Group (Chas. A. Blatchford & Sons Ltd), BioHorizons IPH, Inc., Biomimetics Technology Inc, SynTouch Inc., Vandstrom, Inc., Gelesis, Inc., BioTomo Pty. Ltd., and Hstar Technologies Corporation
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global medical biomimetics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

· Medical Biomimetics Market, By Type:

Cardiovascular
Orthopedic
Ophthalmology
Dental
Others

· Medical Biomimetics Market, By Application

o Wound Healing

o Tissue Engineering

o Drug Delivery

o Plastic Surgery

o Others

· Medical Biomimetics Market, By Region:

North America

United States
Canada
Mexico

Asia-Pacific

China
India
Japan
Australia
South Korea

Europe & CIS

Germany
France
United Kingdom
Spain
Italy

South America

Brazil
Argentina
Colombia

Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

§ Egypt

§ Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Medical Biomimetics Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Medical Biomimetics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Medical Biomimetics Market

5. Voice of Customer

6. Global Medical Biomimetics Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Type (Cardiovascular, Orthopedic, Ophthalmology, Dental, Others)

6.2.2. By Application (Wound Healing, Tissue Engineering, Drug Delivery, Plastic Surgery, Others)

6.2.3. By Region

6.2.4. By Company (2021)

6.3. Market Map

7. North America Medical Biomimetics Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Type

7.2.2. By Application

7.2.3. By Country

7.3. North America: Country Analysis

7.3.1. United States Medical Biomimetics Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Type

7.3.1.2.2. By Application

7.3.2. Canada Medical Biomimetics Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Type

7.3.2.2.2. By Application

7.3.3. Mexico Medical Biomimetics Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Type

7.3.3.2.2. By Application

8. Europe Medical Biomimetics Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Type

8.2.2. By Application

8.2.3. By Country

8.3. Europe: Country Analysis

8.3.1. France Medical Biomimetics Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Type

8.3.1.2.2. By Application

8.3.2. Germany Medical Biomimetics Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Type

8.3.2.2.2. By Application

8.3.3. United Kingdom Medical Biomimetics Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Type

8.3.3.2.2. By Application

8.3.4. Italy Medical Biomimetics Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Type

8.3.4.2.2. By Application

8.3.5. Spain Medical Biomimetics Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Type

8.3.5.2.2. By Application

9. Asia-Pacific Medical Biomimetics Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Type

9.2.2. By Application

9.2.3. By Country

9.3. Asia-Pacific: Country Analysis

9.3.1. China Medical Biomimetics Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Type

9.3.1.2.2. By Application

9.3.2. India Medical Biomimetics Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Type

9.3.2.2.2. By Application

9.3.3. Japan Medical Biomimetics Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Type

9.3.3.2.2. By Application

9.3.4. South Korea Medical Biomimetics Market Outlook

9.3.4.1. Market Size & Forecast

9.3.4.1.1. By Value

9.3.4.2. Market Share & Forecast

9.3.4.2.1. By Type

9.3.4.2.2. By Application

9.3.5. Australia Medical Biomimetics Market Outlook

9.3.5.1. Market Size & Forecast

9.3.5.1.1. By Value

9.3.5.2. Market Share & Forecast

9.3.5.2.1. By Type

9.3.5.2.2. By Application

10. South America Medical Biomimetics Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Type

10.2.2. By Application

10.2.3. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Medical Biomimetics Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Type

10.3.1.2.2. By Application

10.3.2. Argentina Medical Biomimetics Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Type

10.3.2.2.2. By Application

10.3.3. Colombia Medical Biomimetics Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Type

10.3.3.2.2. By Application

11. Middle East and Africa Medical Biomimetics Market Outlook

11.1. Market Size & Forecast

11.1.1. By Value

11.2. Market Share & Forecast

11.2.1. By Type

11.2.2. By Application

11.2.3. By Country

11.3. MEA: Country Analysis

11.3.1. South Africa Medical Biomimetics Market Outlook

11.3.1.1. Market Size & Forecast

11.3.1.1.1. By Value

11.3.1.2. Market Share & Forecast

11.3.1.2.1. By Type

11.3.1.2.2. By Application

11.3.2. Saudi Arabia Medical Biomimetics Market Outlook

11.3.2.1. Market Size & Forecast

11.3.2.1.1. By Value

11.3.2.2. Market Share & Forecast

11.3.2.2.1. By Type

11.3.2.2.2. By Application

11.3.3. UAE Medical Biomimetics Market Outlook

11.3.3.1. Market Size & Forecast

11.3.3.1.1. By Value

11.3.3.2. Market Share & Forecast

11.3.3.2.1. By Type

11.3.3.2.2. By Application

11.3.4. Turkey Medical Biomimetics Market Outlook

11.3.4.1. Market Size & Forecast

11.3.4.1.1. By Value

11.3.4.2. Market Share & Forecast

11.3.4.2.1. By Type

11.3.4.2.2. By Application

11.3.5. Egypt Medical Biomimetics Market Outlook

11.3.5.1. Market Size & Forecast

11.3.5.1.1. By Value

11.3.5.2. Market Share & Forecast

11.3.5.2.1. By Type

11.3.5.2.2. By Application

12. Market Dynamics

12.1. Drivers

12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

14.1. Wright Medical Group N.V.

14.2. Abbott Laboratories, Inc.

14.3. Blatchford Group (Chas. A. Blatchford & Sons Ltd)

14.4. BioHorizons IPH, Inc.

14.5. Biomimetics Technology Inc

14.6. SynTouch Inc.

14.7. Vandstrom, Inc.

14.8. Gelesis, Inc.

14.9. BioTomo Pty. Ltd.

14.10. Hstar Technologies Corporation

15. Strategic Recommendations

Figures and Tables

Frequently asked questions

What are the major drivers for the Global Medical Biomimetics Market?

Growing incidence of chronic diseases, increasing applications of medical biomimetics, and rising technological advancements are driving the demand for the global Medical Biomimetics market.

Who are the top players operating in the global Medical Biomimetics market?

Wright Medical Group N.V., Abbott Laboratories, Inc., Blatchford Group (Chas. A. Blatchford & Sons Ltd), BioHorizons IPH, Inc., Biomimetics Technology Inc, SynTouch Inc., Vandstrom, Inc., Gelesis, Inc., BioTomo Pty. Ltd., and Hstar Technologies Corporation are the key players operating in the global Medical Biomimetics market.

What are the key factors hampering growth for the Global Medical Biomimetics Market?

The high cost associated with medical biomimetics devices, stringent clinical and regulatory requirements may hamper the growth of the global medical biomimetics market.